BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

       

Agilent Technologies Presents 2008 Manfred Donike Award for Sports Doping Control Excellence to German Researcher

SANTA CLARA, Calif., April 18, 2008 -- Agilent Technologies Inc. (NYSE: A), today announced that it has presented the 2008 Manfred Donike Award for scientific excellence in sports doping testing to Ulrich Flenker, research scientist at the Institute of Biochemistry, German Sport University, Cologne, Germany. Flenker was honored for his continuous technical and scientific improvements in detecting doping with synthetic steroids by identifying the ratios of stable isotopes 13C to 12C in samples using gas chromatography-combustion-isotope ratio mass spectrometry (GC-C-IRMS).

Agilent sponsors this annual award to recognize distinguished scientific contributions in doping analysis. Award winners are scientists who exemplify the spirit and scientific leadership of doping-control pioneer Manfred Donike, and whose contributions significantly increase fairness in sports competition. Along with a medallion, there is also a cash prize.

“GC-C-IRMS is now routinely and successfully applied in doping-control laboratories around the world, enabling analysts to discriminate between synthetic and natural steroid hormones to detect doping with compounds like testosterone and its pro-hormones,” said Agilent’s Stephen B. Crisp in presenting the Donike Award at the 26th Cologne Doping Workshop in Cologne, Germany. “We’re pleased to recognize Ulrich’s breakthrough technology with this award.”

Marie Donike, wife of the late professor, made the presentation along with Crisp.

In accepting the award, Flenker acknowledged the work of Svena Ludke in enzyme expression at the Institute of Biochemistry, and the contribution of Dr. Dietmar Schomburg of the University of Cologne.

“This appraisal of my group’s work makes me feel encouraged to continue the stable isotope work,” Flenker said. “Improvement of doping-control issues in the area of stable isotopes doesn’t always happen quickly, and this award is appreciated as an acknowledgement and motivation.”

Flenker was scientific advisor at the lab serving the 2006 Winter Games in Torino, Italy, responsible for stable isotope analysis. He has also served as scientific supervisor at the 2005 IAAF World Championships in Helsinki, Finland, overseeing stable isotope analysis. He has held research positions at the Institute of Biochemistry, German Sport University, Cologne, since 1994. He has degrees in Sports Sciences (German Sport University), Biology (University of Cologne), Master in Sports Sciences and has done doctoral studies on “Application of Stable Isotope Analysis to Doping Control.”

About Agilent in Sports Doping Control

For more than 30 years, Agilent has developed a strong reputation in analytical instruments and methods for drug testing in sports. In 1972, Agilent supplied analytical instrumentation to the lab serving the first Olympic Games in Munich, Germany, in which testing was required. Since then, Agilent technology has played a role with drug-testing labs serving each of the Olympic Games as well as major events such as World Cup Soccer and the Tour de France.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.4 billion in fiscal 2007. Information about Agilent is available on the Web at www.agilent.com .

# # #

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available on the Agilent news site at www.agilent.com/go/news .

Press release URL: http://www.agilent.com/about/newsroom/presrel/2008/17apr-ca08026.html

Additional metadata keywords (for Web use only): sports drug testing, Olympic labs, steroid testing

EDITORIAL CONTACTS:

Claudia Hachtel, Agilent Technologies                         Nicki Muir, Alto Marketing
+49-7243-602 100                                                             +44-1489-55 76 72
claudia_hachtel@agilent.com                                         nickim@alto-marketing.com 

Sarah Perceval, Alto Marketing
+44-1489-55 76 72
sarahp@alto-marketing.com
 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.